(2023). Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models. Lancet Respir Med. http://doi.org/10.1016/s2213-2600(23)00050-4.
(2016). Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. Br J Cancer. http://doi.org/10.1038/bjc.2016.143.
(2021). Selection of eligible participants for screening for lung cancer using primary care data. Thorax. http://doi.org/10.1136/thoraxjnl-2021-217142.